Overview of Ursocol for Laboratory Research
Ursocol 300 mg is a pharmaceutical-grade ursodeoxycholic acid formulation manufactured by Sun Pharmaceuticals Industries Limited. This hepatoprotective bile acid derivative represents a naturally occurring dihydroxy bile acid that constitutes approximately 3% of total bile acids in humans. Researchers worldwide examine ursodeoxycholic acid for its unique physicochemical properties and mechanisms of action in hepatobiliary research models. Our Stroid UK Shop maintains strict quality standards for all laboratory compounds, ensuring researchers receive authentic pharmaceutical materials for their investigational studies.
Research Applications in Hepatobiliary Studies
Scientists investigate Ursocol’s hydrophilic properties and cytoprotective mechanisms across multiple research paradigms. Laboratory studies examine its ability to replace more hydrophobic, toxic bile acids in experimental models of cholestatic liver conditions. Research teams analyse its effects on hepatocyte membrane stabilisation and its capacity to stimulate choleresis in animal models. The compound’s anti-apoptotic properties make it valuable for studying cellular protection mechanisms in hepatic injury models. Investigators also examine its immunomodulatory effects and potential neuroprotective properties in various experimental frameworks. Hepatoprotective research compounds like Ursocol enable comprehensive studies of bile acid metabolism and therapeutic mechanisms.
Product Specifications and Storage
| Parameter | Value |
|---|---|
| Active Ingredient | Ursodeoxycholic Acid |
| Strength | 300 mg per tablet |
| Manufacturer | Sun Pharmaceuticals Industries Ltd |
| Molecular Formula | C₂₄H₄₀O₄ |
| Molecular Weight | 392.57 g/mol |
| CAS Number | 128-13-2 |
| Storage Conditions | Room temperature, dry environment |
| Shelf Life | As per manufacturer specifications |
Researchers working with similar metabolic modulators often incorporate compounds from our selective androgen receptor modulators collection or research peptides section for comprehensive metabolic pathway investigations.
Compliance and Safety Information
This product is intended strictly for in-vitro research and laboratory analytical purposes only. Ursocol 300 mg is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must handle this compound according to appropriate laboratory safety protocols and institutional guidelines. All experimental work should be conducted by qualified personnel in properly equipped research facilities with adequate ventilation and safety measures. This material is provided solely for legitimate scientific research purposes.
